Non-tuberculosis opportunistic infections and other lung diseases in HIV-infected infants and children

International Journal of Tuberculosis and Lung Disease

Volumn 9, Issue 6, 2005, Pages 592-602

  Graham, Stephen M ^a,b,c  

^a UNIVERSITY OF MALAWI   (Malawi)

^b LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^c MALAWI LIVERPOOL WELLCOME TRUST CLINICAL RESEARCH PROGRAMME   (Malawi)

Author keywords

Bacterial pneumonia; Cytomegalovirus; Fungal pneumonia; Lymphoid interstitial pneumonia; Pneumocystis jirovecii pneumonia

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; ANTIRETROVIRUS AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; COTRIMOXAZOLE; MEASLES VACCINE; PREDNISONE; RETINOL; THALIDOMIDE; VINCRISTINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBIOTIC PROPHYLAXIS; ARTIFICIAL VENTILATION; BACTERIAL PNEUMONIA; BRONCHIECTASIS; CHILD; CHILDHOOD DISEASE; CHILDHOOD MORTALITY; CLINICAL FEATURE; CYTOMEGALOVIRUS; DEVELOPING COUNTRY; DIFFERENTIAL DIAGNOSIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; INFANT; INFANT DISEASE; INFANT MORTALITY; KAPOSI SARCOMA; LUNG DISEASE; LUNG INFECTION; LYMPHOID INTERSTITIAL PNEUMONITIS; MAJOR CLINICAL STUDY; MEASLES; MEASLES VACCINATION; OPEN LUNG BIOPSY; OPPORTUNISTIC INFECTION; PHYSIOTHERAPY; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESPIRATORY DISTRESS; REVIEW; THORAX RADIOGRAPHY; VIRUS PNEUMONIA; WORLD HEALTH ORGANIZATION;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; LUNG DISEASES; LUNG DISEASES, INTERSTITIAL; LYMPHOPROLIFERATIVE DISORDERS; PNEUMOCYSTIS JIROVECI; PNEUMONIA, PNEUMOCYSTIS; PNEUMONIA, VIRAL;

EID: 20444502921     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (69)

1. Graham S M, Gibb D M. HIV disease and respiratory infection in children. Br Med Bull 2002; 61: 133-150.
2. Perez M S, Van Dyke R B. Pulmonary infections in children with HIV infection. Semin Respir Infect 2002; 17: 33-46.
3. Chearskul S, Chotpitayasunondh T, Simonds R J, et al. Survival, disease manifestations, and early predictors of disease progression among children with perinatal human immunodeficiency virus infection in Thailand. Pediatrics 2002; 110: e25.
4. Graham S M. Impact of HIV on childhood respiratory illness: differences between developing and developed countries. Pediatr Pulmonol 2003; 36: 462-468.
5. Mofenson L M, Oleske J, Serchuck L, Van Dyke R, Wilfert C. Treating opportunistic infections among HIV-exposed and infected children: recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of America. Clin Infect Dis 2005; 40 (Suppl 1): S1-S84.
6. Palme I B, Gudetta B, Bruchfeld J, Muhe L, Giesecke J. Impact of human immunodeficiency virus 1 infection on clinical presentation, treatment outcome and survival in a cohort of Ethiopian children with tuberculosis. Pediatr Infect Dis J 2002; 21: 1053-1061.
7. Jeena P M, Pillay P, Pillay T, Coovadia H M. Impact of HIV-1 co-infection on presentation and hospital-related mortality in children with culture proven pulmonary tuberculosis in Durban, South Africa. Int J Tuberc Lung Dis 2002; 6: 672-678.
8. Dankner W M, Lindsey J C, Levin M J. Correlates of opportunistic infections in children infected with the human immunodeficiency virus managed before highly active antiretroviral therapy. Pediatr Infect Dis J 2001; 20: 40-48.
9. Balarezo F S, Joshi V V. Proliferative and neoplastic disorders in children with acquired immunodeficiency syndrome. Adv Anat Pathol 2002; 9: 360-370.
10. Kiwanuka J, Graham S M, Coulter J B, et al. Diagnosis of pulmonary tuberculosis in children in an HIV-endemic area, Malawi. Ann Trop Paediatr 2001; 21: 5-14.
11. Ranjana K H, Priyokumar K, Singh T J, et al. Disseminated Penicillium marneffei infection among HIV-infected patients in Manipur state, India. J Infect 2002; 45: 268-271.
12. Duong T A. Infection due to Penicillium marneffei, an emerging pathogen: review of 155 reported cases. Clin Infect Dis 1996; 23: 125-130.
13. Graham S M, Mtitimila E I, Kamanga H S, Walsh A L, Hart C A, Molyneux M E. Clinical presentation and outcome of Pneumocystis carinii pneumonia in Malawian children. Lancet 2000; 355: 369-373.
14. Zar H J, Hanslo D, Tannenbaum E, et al. Aetiology and outcome of pneumonia in human immunodeficiency virus-infected children hospitalized in South Africa. Acta Paediatr 2001; 90: 119-125.
15. Bakeera-Kitaka S, Musoke P, Downing R, Tumwine J K. Pneumocystis carinii in children with severe pneumonia at Mulago Hospital, Uganda. Ann Trop Paediatr 2004; 24: 227-235.
16. Lucas S B, Peacock C S, Hounnou A, et al. Disease in children infected with HIV in Abidjan, Cote d'Ivoire. BMJ 1996; 312: 335-338.
17. Chintu C, Mudenda V, Lucas S, et al. Lung diseases at necropsy in African children dying from respiratory illnesses: a descriptive necropsy study. Lancet 2002; 360: 985.
18. Ansari N A, Kombe A H, Kenyon T A, et al. Pathology and causes of death in a series of human immunodeficiency virus-positive and -negative pediatric referral hospital admissions in Botswana. Pediatr Infect Dis J 2003; 22: 43-47.
19. Madhi S A, Petersen K, Madhi A, Khoosal M, Klugman K P. Increased disease burden and antibiotic resistance of bacteria causing severe community-acquired lower respiratory tract infections in human immunodeficiency virus type 1-infected children. Clin Infect Dis 2000; 31: 170-176.
20. Duong T, Ades A E, Gibb D M, Tookey P A, Masters J. Vertical transmission rates for HIV in the British Isles: estimates based on surveillance data. BMJ 1999; 319: 1227-1229.
21. Fallo A A, DobrzanskiNisiewicz W, Sordelli N, Cattaneo M A, Scott G, Lopez E L. Clinical and epidemiologic aspects of human immunodeficiency virus-1-infected children in Buenos Aires, Argentina. Int J Infect Dis 2002; 6: 9-16.
22. Shann F, Walters S, Pifer L L, et al. Pneumonia associated with infection with pneumocystis, respiratory syncytial virus, chlamydia, mycoplasma, and cytomegalovirus in children in Papua New Guinea. Br Med J (Clin Res Ed) 1986; 292: 314-317.
23. Wakefield A E. Pneumocystis carinii. Br Med Bull 2002; 61: 175-188.
24. Stringer J R, Beard C B, Miller R F, Wakefield A E. A new name (Pneumocystis jiroveci) for Pneumocystis from humans. Emerg Infect Dis 2002; 8: 891-896.
25. Dumoulin A, Mazars E, Seguy N, et al. Transmission of Pneumocystis carinii disease from immunocompetent contacts of infected hosts to susceptible hosts. Eur J Clin Microbiol Infect Dis 2000; 19: 671-678.
26. Miller R F, Ambrose H E, Novelli V, Wakefield A E. Probable mother-to-infant transmission of Pneumocystis carinii f. sp. hominis infection. J Clin Microbiol 2002; 40: 1555-1557.
27. Miller R F, Ambrose H E, Wakefield A E. Pneumocystis carinii f. sp. hominis DNA in immunocompetent health care workers in contact with patients with P. carinii pneumonia. J Clin Microbiol 2001; 39: 3877-3882.
28. Kovacs J A, Gill V J, Meshnick S, Masur H. New insights into transmission, diagnosis, and drug treatment of Pneumocystis carinii pneumonia. JAMA 2001; 286: 2450-2460.
29. Maskell N A, Waine D J, Lindley A, et al. Asymptomatic carriage of Pneumocystis jiroveci in subjects undergoing bronchoscopy: a prospective study. Thorax 2003; 58: 594-597.
30. Kasolo F, Lishimpi K, Chintu C, et al. Identification of Pneumocystis carinii DNA by polymerase chain reaction in necropsy lung samples from children dying of respiratory tract illnesses. J Pediatr 2002; 140: 367-369.
31. Sing A, Trebesius K, Roggenkamp A, et al. Evaluation of diagnostic value and epidemiological implications of PCR for Pneumocystis carinii in different immunosuppressed and immunocompetent patient groups. J Clin Microbiol 2000; 38: 1461-1467.
32. Varela J M, Regordan C, Medrano F J, et al. Climatic factors and Pneumocystis jiroveci infection in southern Spain. Clin Microbiol Infect 2004; 10: 770-772.
33. Williams A J, Duong T, McNally L M, et al. Pneumocystis carinii pneumonia and cytomegalovirus infection in children with vertically acquired HIV infection. AIDS 2001; 15: 335-339.
34. Jeena P M, Coovadia H M, Chrystal V. Pneumocystis carinii and cytomegalovirus infections in severely ill, HIV-infected African infants. Ann Trop Paediatr 1996; 16: 361-368.
35. Madhi S A, Cutland C, Ismail K, O'Reilly C, Mancha A, Klugman K P. Ineffectiveness of trimethoprim-sulfamethoxazole prophylaxis and the importance of bacterial and viral coinfections in African children with Pneumocystis carinii pneumonia. Clin Infect Dis 2002; 35: 1120-1126.
36. Zar H J, Alvarez-Martinez M J, Harrison A, Meshnick S R. Prevalence of dihydropteroate synthase mutants in HIV-infected South African children with Pneumocystis jiroveci pneumonia. Clin Infect Dis 2004; 39: 1047-1051.
37. Thirsk E R, Kapongo M C, Jeena P M, et al. HIV-exposed infants with acute respiratory failure secondary to acute lower respiratory infections managed with and without mechanical ventilation. S Afr Med J 2003; 93: 617-620.
38. Sheikh S, Bakshi S S, Pahwa S G. Outcome and survival in HIV-infected infants with Pneumocystis carinii pneumonia and respiratory failure. Pediatr AIDS HIV Infect 1996; 7: 155-163.
39. Jensen A M, Lundgren J D, Benfield T, Nielsen T L, Vestbo J. Does cytomegalovirus predict a poor prognosis in Pneumocystis carinii pneumonia treated with corticosteroids? A note for caution. Chest 1995; 108: 411-414.
40. World Health Organization. Joint WHO/UNAIDS/UNICEF Statement on use of cotrimoxazole as prophylaxis in HIV-exposed and HIV-infected children. Geneva, Switzerland: WHO, 2004.
41. Kaplan J E, Masur H, Holmes K K. Guidelines for preventing opportunistic infections among HIV-infected persons-2002. Recommendations of the US Public Health Service and the Infectious Diseases Society of America. MMWR Recomm Rep 2002; 51: 1-52.
42. Graham S M. Prophylaxis against Pneumocystis carinii pneumonia for HIV-exposed infants in Africa. Lancet 2002; 360: 1966-1968.
43. Gill C J, Sabin L L, Tham J, Hamer D H. Reconsidering empirical cotrimoxazole prophylaxis for infants exposed to HIV infection. Bull World Health Organ 2004; 82: 290-297.
44. Graham S M. Cotrimoxazole prophylaxis for infants exposed to HIV infection. Bull World Health Organ 2004; 82: 297-298.
45. Newell M L, Coovadia H, Cortina-Borja M, Rollins N, Gaillard P, Dabis F. Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet 2004; 364: 1236-1243.
46. Chintu C, Bhat G J, Walker A S, et al. Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial. Lancet 2004; 364: 1865-1871.
47. Moss W J, Monze M, Ryon J J, Quinn T C, Griffin D E, Cutts F. Prospective study of measles in hospitalized, human immunodeficiency virus (HIV)-infected and HIV-uninfected children in Zambia. Clin Infect Dis 2002; 35: 189-196.
48. Hussey G D, Klein M. A randomized, controlled trial of vitamin A in children with severe measles. N Engl J Med 1990; 323: 160-164.
49. Moss W J, Clements C J, Halsey N A. Immunization of children at risk of infection with human immunodeficiency virus. Bull World Health Organ 2003; 81: 61-70.
50. Moraes-Pinto M I, Verhoeff F, Chimsuku L, et al. Placental antibody transfer: influence of maternal HIV infection and placental malaria. Arch Dis Child Fetal Neonatal Ed 1998; 79: F202-F205.
51. Jeena P. Role of HIV infection in acute respiratory infections among children in sub-Saharan Africa. [State of the Art] Int J Tuberc Lung Dis 2005; 9 (in press).
52. Madhi S A, Schoub B, Simmank K, Blackburn N, Klugman K P. Increased burden of respiratory viral associated severe lower respiratory tract infections in children infected with human immunodeficiency virus type-1. J Pediatr 2000; 137: 78-84.
53. Jeena P M, Coovadia H M, Thula S A, Blythe D, Buckels N J, Chetty R. Persistent and chronic lung disease in HIV-1 infected and uninfected African children. AIDS 1998; 12: 1185-1193.
54. Sharland M, Gibb D M, Holland F. Respiratory morbidity from lymphocytic interstitial pneumonitis (LIP) in vertically acquired HIV infection. Arch Dis Child 1997; 76: 334-336.
55. Mueller G A, Pickoff A S. Pediatric lymphocytic interstitial pneumonitis in an HIV-negative child with pulmonary Epstein-Barr virus infection. Pediatr Pulmonol 2003; 36: 447-449.
56. Andiman W A, Eastman R, Martin K, et al. Opportunistic lymphoproliferations associated with Epstein-Barr viral DNA in infants and children with AIDS. Lancet 1985; 2: 1390-1393.
57. Ikeogu M O, Wolf B, Mathe S. Pulmonary manifestations in HIV seropositivity and malnutrition in Zimbabwe. Arch Dis Child 1997; 76: 124-128.
58. Zar H J, Hussey G. Finger clubbing in children with human immunodeficiency virus infection. Ann Trop Paediatr 2001; 21: 15-19.
59. Sheikh S, Madiraju K, Steiner P, Rao M. Bronchiectasis in pediatric AIDS. Chest 1997; 112: 1202-1207.
60. McKinsey D S, Spiegel R A, Hutwagner L, et al. Prospective study of histoplasmosis in patients infected with human immunodeficiency virus: incidence, risk factors, and pathophysiology. Clin Infect Dis 1997; 24: 1195-1203.
61. Carme B, Ngaporo A I, Ngolet A, Ibara J R, Ebikili B. Disseminated African histoplasmosis in a Congolese patient with AIDS. J Med Vet Mycol 1992; 30: 245-248.
62. Speed B, Dunt D. Clinical and host differences between infections with the two varieties of Cryptococcus neoformans. Clin Infect Dis 1995; 21: 28-34.
63. Bodasing N, Seaton R A, Shankland G S, Kennedy D. Cryptococcus neoformans var. gattii meningitis in an HIV-positive patient: first observation in the United Kingdom. J Infect 2004; 49: 253-255.
64. Seaton R A, Wembri J P, Armstrong P, Ombiga J, Naraqi S, Kevau I. Symptomatic human immunodeficiency virus (HIV) infection in Papua New Guinea. Aust NZJ Med 1996; 26: 783-788.
65. Elenga N, Kouakoussui K A, Bonard D, et al. [Non tuberculous mycobacterial infections in children with AIDS in Abidjan (Ivory Coast)]. Arch Pediatr 2004; 11: 864-866.
66. Pintado V, Gomez-Mampaso E, Cobo J, et al. Nocardial infection in patients infected with the human immunodeficiency virus. Clin Microbiol Infect 2003; 9: 716-720.
67. Shata A M, Coulter J B, Parry C M, Ching'ani G, Broadhead R L, Hart C A. Sputum induction for the diagnosis of tuberculosis. Arch Dis Child 1996; 74: 535-537.
68. Wheat J, Sarosi G, McKinsey D, et al. Practice guidelines for the management of patients with histoplasmosis. Infectious Diseases Society of America. Clin Infect Dis 2000; 30: 688-695.
69. Amir H, Kaaya E E, Manji K P, Kwesigabo G, Biberfeld P. Kaposi's sarcoma before and during a human immunodeficiency virus epidemic in Tanzanian children. Pediatr Infect Dis J 2001; 20: 518-521.